August 3, 2025

Critical role of ongoing EA9181 trial for Ph+ ALL highlighted in Blood Cancers Today

July 16, 2025

European Hematology Association highlights E1910 data showing improved survival in younger B-cell ALL patients aged 30-54

July 15, 2025

Consolidation blinatumomab with chemotherapy improves survival in younger B-cell ALL patients aged 30-54 (study E1910)

June 11, 2025

The June 2025 News from ECOG-ACRIN blog is now available

March 5, 2025

LISTEN: A JAMA Network Learning podcast interview with Dr. Anand Jillella, author of the newly published results of study EA9131 in JAMA Oncology

January 5, 2025

NCI’s myeloMATCH precision medicine initiative pushes the envelop in myeloid leukemia care

November 25, 2024

Press Release: ECOG-ACRIN adds a late-breaking abstract to its ASH 2024 presentation line-up

October 30, 2024

WATCH: Behind the ECOG-ACRIN E1910 trial with lead investigator Dr. Mark Litzow

August 21, 2024

How a patient’s role in a clinical trial for acute lymphocytic leukemia brought a cancer-free diagnosis, FDA approval

ECOG-ACRIN Cancer Research Group